EBV LMP2 peptide FLYALALLL (HLA-A*0201)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
EBV LMP2 peptide FLYALALLL (HLA-A*0201)

EBV LMP2 peptide FLYALALLL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from human Epstein-Barr virus (EBV) latent membrane protein 2 (LMP2) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: FLYALALLL
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-A*0201

Podobne produkty

CD22-4 peptide RLLGKESQL (HLA-A*0201)

CD22-4 peptide RLLGKESQL (HLA-A*0201)

IBA Lifescience
Więcej
PPI peptide ALWMRLLPL (HLA-A*0201)

PPI peptide ALWMRLLPL (HLA-A*0201)

IBA Lifescience
Więcej
SARS-CoV-2 peptide FIAGLIAIV (HLA-A*0201)

SARS-CoV-2 peptide FIAGLIAIV (HLA-A*0201)

IBA Lifescience
Więcej